These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25300947)
1. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. Camilo V; Barros R; Celestino R; Castro P; Vieira J; Teixeira MR; Carneiro F; Pinto-de-Sousa J; David L; Almeida R BMC Cancer; 2014 Oct; 14():753. PubMed ID: 25300947 [TBL] [Abstract][Full Text] [Related]
2. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients. Ribeirinho-Soares S; Pádua D; Amaral AL; Valentini E; Azevedo D; Marques C; Barros R; Macedo F; Mesquita P; Almeida R BMC Cancer; 2021 Apr; 21(1):359. PubMed ID: 33823840 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional factor typing with SOX2, HNF4aP1, and CDX2 closely relates to tumor invasion and Epstein-Barr virus status in gastric cancer. Uozaki H; Barua RR; Minhua S; Ushiku T; Hino R; Shinozaki A; Sakatani T; Fukayama M Int J Clin Exp Pathol; 2011 Mar; 4(3):230-40. PubMed ID: 21487519 [TBL] [Abstract][Full Text] [Related]
5. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer. Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618 [TBL] [Abstract][Full Text] [Related]
6. Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa. Barros R; Pereira D; Callé C; Camilo V; Cunha AI; David L; Almeida R; Dias-Pereira A; Chaves P Dis Markers; 2016; 2016():1532791. PubMed ID: 27766003 [TBL] [Abstract][Full Text] [Related]
7. Sox2 expression is maintained while gastric phenotype is completely lost in Cdx2-induced intestinal metaplastic mucosa. Mutoh H; Sashikawa M; Sugano K Differentiation; 2011 Feb; 81(2):92-8. PubMed ID: 21036460 [TBL] [Abstract][Full Text] [Related]
8. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2. Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071 [TBL] [Abstract][Full Text] [Related]
9. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879 [TBL] [Abstract][Full Text] [Related]
10. Dysregulation of CDX1, CDX2 and SOX2 in patients with gastric cancer also affects the non-malignant mucosa. Bornschein J; Tóth K; Selgrad M; Kuester D; Wex T; Molnár B; Tulassay Z; Malfertheiner P J Clin Pathol; 2013 Sep; 66(9):819-22. PubMed ID: 23613102 [TBL] [Abstract][Full Text] [Related]
11. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis. Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells. Camilo V; Barros R; Sousa S; Magalhães AM; Lopes T; Mário Santos A; Pereira T; Figueiredo C; David L; Almeida R Carcinogenesis; 2012 Oct; 33(10):1985-92. PubMed ID: 22791809 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation. Yoon JH; Choi SS; Kim O; Choi WS; Park YK; Nam SW; Lee JY; Park WS Mod Pathol; 2016 Feb; 29(2):194-208. PubMed ID: 26743476 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585 [TBL] [Abstract][Full Text] [Related]
15. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer. Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma]. Xiong ZF; Xiao H; Tan YS Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171 [TBL] [Abstract][Full Text] [Related]
17. CDX2 as a prognostic marker in gastric cancer. Masood MA; Loya A; Yusuf MA Acta Gastroenterol Belg; 2016; 79(2):197-200. PubMed ID: 27382937 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression. Asonuma S; Imatani A; Asano N; Oikawa T; Konishi H; Iijima K; Koike T; Ohara S; Shimosegawa T Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G312-22. PubMed ID: 19520737 [TBL] [Abstract][Full Text] [Related]
19. Disturbed balance between SOX2 and CDX2 in human vitelline duct anomalies and intestinal duplications. Raghoebir L; Biermann K; Buscop-van Kempen M; Wijnen RM; Tibboel D; Smits R; Rottier RJ Virchows Arch; 2013 May; 462(5):515-22. PubMed ID: 23568430 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures. Wang XT; Wei WY; Kong FB; Lian C; Luo W; Xiao Q; Xie YB J Exp Clin Cancer Res; 2012 Nov; 31(1):98. PubMed ID: 23181722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]